The price control of stents will result in annual savings of about Rs 4,450 crore for patients, Parliament was informed on Tuesday.
Minister of State for Chemicals Mansukh L Mandaviya said in a written reply to the Lok Sabha:
The National Pharmaceutical Pricing Authority (NPPA) had notified the ceiling price of coronary stents at Rs 7,260 for bare metal stent and Rs 29,600 for drug-eluting ones.
The corresponding average MRPs before the notification stood at Rs 45,100 and Rs 1.21 lakh.
In a separate reply, the minister said the NPPA has directed hospitals to issue detailed bills to patients, specifically and separately mentioning cost of the coronary stents along with brand name of manufacturer or importer and other details.
The government has alerted the states and state drug controllers to monitor the availability of stents, he said.
The NPPA already has conducted two rounds of discussions with the stent companies which in turn have promised required level of availability.
(At The Quint, we question everything. Play an active role in shaping our journalism by becoming a member today.)
Published: undefined